Standing stability among women with epidural pain relief after Cesarean delivery

Posturography can detect potential impairment of standing stability due to epidural fentanyl after Cesarean delivery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14517337

Enrollment

Registered

2020-03-31

Start date

2018-05-01

Completion date

Unknown

Last updated

2021-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal anesthesia during an elective Cesarean delivery Pregnancy and Childbirth

Interventions

Continuous epidural infusion of 0.2% ropivacaine containing either 2.5 mcg/ml (Group 1) or 5 mcg/ml fentanyl (Group 2) is randomly assigned to an individual and started at the rate of 5 ml/h postopera

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Term pregnant woman with ASA I or II 2. Elective Cesarean delivery 3. Received an epidural catheter at T12/L1 following spinal anesthesia

Exclusion criteria

Exclusion criteria: 1. ASA III or higher 2. Needs an urgent Cesarean delivery 3. Needs general anesthesia for a Cesarean delivery

Design outcomes

Primary

Measure	Time frame
Sway area measured by a posturography at baseline, one and seven days after Cesarean delivery	—

Secondary

Measure	Time frame
1. Pain status with Visual Analogue Scale once a day after Cesarean delivery up to post-operative seven days 2. Motor function of legs with Bromage scale on post-operative day one	—

Countries

Japan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 22, 2026